Bio Essence Corp
BIOE· OTC
BIOEBio Essence Corp
Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001213900-24-098180
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $134.69K | $155.70K | $192.05K | $226.99K |
| Net Income | -$1.20M | -$314.84K | -$199.23K | -$183.04K |
| EPS Diluted | -$0.03 | -$0.01 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end
